Basilea initiates targeted biomarker-driven phase 2 study with lisavanbulin in patients with brain cancer

NEXT STORY
Global Licorice Root Market Report 2020-2026 Featuring Profiles of Producers – NOREVO GmbH, Herbs Iran, Naturex SA
PREV STORY
Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receipt of $15 Million Upfront Payment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of TransCon™ PTH (palopegteriparatide) in Adults with Hypoparathyroidism (HP) and Provides a Comprehensive Global Clinical Program Update

author_avatar
NASDAQ Market News

Sweegen Delights China’s Consumers With Premiumization of Low-Calorie Confectionery Chocolate

author_avatar
NASDAQ Market News

Principal Investigator Dr. James Gulley to Provide Presentation Entitled “Therapeutic Vaccines in Prostate Cancer” at the ESMO 2017 Congress

MADRID, September 11, 2017 - This morning at the European Society for Medical Oncology ...

author_avatar
NASDAQ Market News